The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men With Obesity and Insulin Resistance. Glob. Scie. Revi. 2026, 48, 42-45.